N-(2-Fluorophenyl)-2-{N-[3-(trifluoromethyl)phenyl]4-chlorobenzenesulfonamido}acetamide

Catalog No. :
ACBHAH149
CAS No. :
337922-23-3
Molecular Formula :
C21H15ClF4N2O3S
Molecular Weight :
486.87

IUPAC Name:2-((4-chloro-N-(3-(trifluoromethyl)phenyl)phenyl)sulfonamido)-N-(2-fluorophenyl)acetamide

N-(2-Fluorophenyl)-2-{N-[3-(trifluoromethyl)phenyl]4-chlorobenzenesulfonamido}acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg90%$187.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Fluorophenyl)-2-{N-[3-(trifluoromethyl)phenyl]4-chlorobenzenesulfonamido}acetamide
IUPAC Name2-((4-chloro-N-(3-(trifluoromethyl)phenyl)phenyl)sulfonamido)-N-(2-fluorophenyl)acetamide
Molecular FormulaC21H15ClF4N2O3S
Molecular Weight486.87
SMILESO=C(NC1=CC=CC=C1F)CN(C2=CC=CC(C(F)(F)F)=C2)S(=O)(C3=CC=C(Cl)C=C3)=O
InChI KeyNWRKZDXDLYJRAQ-UHFFFAOYSA-N
Synonym2-[[(4-CHLOROPHENYL)SULFONYL]-3-(TRIFLUOROMETHYL)ANILINO]-N-(2-FLUOROPHENYL)ACETAMIDE;N-(2-fluorophenyl)-2-{N-[3-(trifluoromethyl)phenyl]4-chlorobenzenesulfonamido}acetamide;Acetamide, 2-[[(4-chlorophenyl)sulfonyl][3-(trifluoromethyl)phenyl]amino]-N-(2-fluorophenyl)-
CAS No.337922-23-3

Synthetic Route by SureRoute

1. ACBHAH149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPRQH198 route compound structure diagram
    ACPRQH19851085-49-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHAH149 route product structure diagram
    ACBHAH149337922-23-3
Inquiry

2. ACBHAH149 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTLIJ085 route compound structure diagram
    ACTLIJ08573383-95-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBHAH149 route product structure diagram
    ACBHAH149337922-23-3
Inquiry

Comments (0)